Skip to main content
STADA Arzneimittel AG logo

STADA Arzneimittel AG — Investor Relations & Filings

Ticker · SAZ ISIN · DE0007251803 LEI · 529900FMTTLMH0P0DL10 HM Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2021-03-03 Report Publication Anno…
Country DE Germany
Listing HM SAZ

About STADA Arzneimittel AG

https://www.stada.com/

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Recent filings

Filing Released Lang Actions
Hinweis auf Jahresfinanzbericht vom 01.01.2020 bis zum 31.12.2020
Report Publication Announcement Classification · 100% confidence The document is a short notification (783 characters) announcing the availability of the Annual Financial Report for the period 01.01.2020 to 31.12.2020. It provides a link to the report rather than containing the report itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2021-03-03 German
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 24.09.2020 in Bad Vilbel mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 98% confidence The document text explicitly announces the convening ('Einberufung') of a General Meeting ('Hauptversammlung') for STADA Arzneimittel Aktiengesellschaft scheduled for September 24, 2020. It also mentions the publication ('Bekanntmachung über die Veröffentlichung') of supplementary documents related to this extraordinary General Meeting and provides a link where these materials are accessible. Since the core purpose is the announcement and scheduling of the AGM, and it references supplementary materials for that meeting, the most appropriate classification is AGM Information (AGM-R). Although it mentions the publication of documents, the primary focus is the meeting itself, not just the announcement of a report release (RPA).
2020-09-16 German
Datum:26.08.2020
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Zwischenbericht 1. Halbjahr 2020' (Interim Report 1st Half 2020) for STADA Arzneimittel AG. It contains detailed financial tables (Konzern-Kennzahlen), management commentary (Zusammengefasster Konzernzwischenlagebericht), and analysis of revenue and earnings development for the first six months of the fiscal year. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2020
2020-08-26 German
STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 24.09.2020 in Bad Vilbel mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 98% confidence The document is explicitly titled 'Bekanntmachung der Einberufung zur Hauptversammlung' (Announcement of the Convocation to the General Meeting) and repeatedly refers to the 'außerordentlichen Hauptversammlung 2020' (Extraordinary General Meeting 2020). It details the date, time, virtual format due to COVID-19, the sole agenda item (a squeeze-out resolution), and instructions for shareholder participation and accessing related documents. This content directly corresponds to the materials distributed to shareholders in advance of an AGM, which falls under the definition of AGM Information (AGM-R) or, more specifically, the announcement/invitation materials for it. Since the document is an invitation/convocation notice for the AGM, AGM-R is the most appropriate classification, as it relates directly to the meeting itself, rather than a general regulatory filing (RNS) or a proxy statement (PSI) which usually solicits votes for multiple items.
2020-08-17 German
Report Publication Announcement 2020
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that it is announcing *when* and *where* the "Financial report (half-year/Q2)" will be disclosed on August 26, 2020, providing links to the future location. Since the document itself is an announcement about the publication of a report (a half-year report, which typically falls under Interim/Quarterly Report (IR)), and not the report content itself, it fits the definition of a Report Publication Announcement (RPA). The document length is very short (1728 chars), supporting the 'MENU VS MEAL' rule.
2020-08-10 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2020 bis zum 30.06.2020
Report Publication Announcement Classification · 100% confidence The document is a short notification (784 characters) informing stakeholders that the company's half-year financial report is available for download via a provided URL. It does not contain the financial report itself, but rather serves as an announcement of its publication. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2020-08-10 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.